M&A / Deals

Arcera and Fosun sign MoU for neuroscience innovation

Pharmaceutical Business Review

The initiative aligns with China's and the United Arab Emirates' (UAE) broader strategic objectives to enhance healthcare and the life sciences industry.

Neuroscience

Read full story

pharminent April 29, 2026 (Last updated: April 29, 2026)

Pharmaceutical Business Review

The initiative aligns with China’s and the United Arab Emirates’ (UAE) broader strategic objectives to enhance healthcare and the life sciences industry.

Neuroscience

Read full story

Related Stories

Eli Lilly to buy trio of vaccine developers in $3.8bn outlay

Gilead inks $140M API supply deal, tightening ties to Korean manufacturer

GBL joins CVC in 10.7bn takeover bid for Recordati

You May Have Missed

Eli Lilly to buy trio of vaccine developers in $3.8bn outlay

Arthrosi drug trial in gout delivers for new owner Sobi

Lilly’s Verve gambit pays off as base editor cuts cholesterol in early study

Pierre Fabre’s Braftovi gains CHMP positive opinion for mCRC